Recombinant Human CCL3L1 Protein，His & GST

CCL3L1, also known as macrophage inflammatory protein-1-like protein 1, is a member of the CC chemokine family and plays a crucial role in immune responses. Its primary function involves recruiting immune cells, particularly T cells and monocytes, to sites of inflammation or infection. Research has shown that variations in CCL3L1 gene copy number are associated with susceptibility to various diseases, including autoimmune disorders, infectious diseases, and certain cancers. Notably, lower gene copy numbers have been linked to an increased risk of HIV infection and progression to AIDS, highlighting its potential as a biomarker for disease vulnerability. Furthermore, CCL3L1 is involved in various physiological processes, including angiogenesis and tissue remodeling, thus suggesting its relevance in both innate and adaptive immunity. Recent studies have explored the development of recombinant CCL3L1 proteins to investigate their therapeutic potential and elucidate their role in modulating immune responses. By producing and studying recombinant CCL3L1, researchers aim to better understand its mechanisms of action and explore its applications in immunotherapy and vaccine development. Overall, the study of CCL3L1 and its recombinant forms holds promise for advancing knowledge in immunology and developing novel therapeutic strategies for various conditions where immune modulation is beneficial.